The Potential Protective Effect and Underlying Mechanisms of Physiological Unconjugated Hyperbilirubinemia Mediated by UGT1A1 Antisense Oligonucleotide Therapy in a Mouse Model of Cyclosporine A-Induced Chronic Kidney Disease
Cyclosporine A (CSA) is an immunosuppressive drug that has improved transplant survival rates. However, its use is often limited because it is thought to be linked to the development of chronic kidney disease after kidney transplants. This study aimed to investigate the protective effects and underl...
Main Authors: | Basma H. Marghani, Mohamed El-Adl, Ahmed I. Ateya, Basma H. Othman, Heba I. Ghamry, Mustafa Shukry, Mohamed Mohamed Soliman, Mohamed Abdo Rizk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/10/999 |
Similar Items
-
Profiling of UGT1A1*6, UGT1A1*60, UGT1A1*93, and UGT1A1*28 Polymorphisms in Indonesian Neonates With Hyperbilirubinemia Using Multiplex PCR Sequencing
by: Radhian Amandito, et al.
Published: (2019-08-01) -
Unconjugated Neonatal Hyperbilirubinemia: Evaluation and Treatment
by: Zaid T Yaseen, et al.
Published: (2020-12-01) -
Unconjugated Neonatal Hyperbilirubinemia: Evaluation and Treatment
by: Zaid T Yaseen, et al.
Published: (2020-12-01) -
Etiologies of Prolonged Unconjugated Hyperbilirubinemia in Neonates Admitted to Neonatal Wards
by: Mohammad Kazem Sabzehei, et al.
Published: (2015-12-01) -
Gilbert or Crigler–Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity
by: Laura Cozzi, et al.
Published: (2022-04-01)